ISSX NA 2021: An Integrated Radiolabelled Study to Determine the Mass Balance, Metabolite Profile and Identification and absolute bioavailability of Nolasiban in Healthy Female Subjects

Presented at the 24th North American ISSX Meeting, in this poster, we determine Mass Balance, Metabolite Profile and Identification and Absolute Bioavailability of Nolasiban in Healthy Female Subjects, via an integrated radiolabelled study.

This open-label study was conducted in two cohorts of six subjects. Approvals were obtained from the Medicines and Healthcare products Regulatory Agency, Ethics and the Administration of Radioactive